Streamex Corp. (STEX)
NASDAQ: STEX · Real-Time Price · USD
4.140
+0.410 (10.99%)
Nov 18, 2025, 4:00 PM EST - Market closed
Company Description
Streamex Corp., a real world asset (RWA) tokenization company with Institutional grade infrastructure.
It offers gold denominated treasury and tokenization technology to commodities markets. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025.
Streamex Corp. was incorporated in 2009 and is based in Winter Park, Florida.
Streamex Corp.
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Karl McPhie |
Contact Details
Address: 2431 Aloma Avenue, Suite 243 Winter Park, Florida 32792 United States | |
| Phone | 203 409 5444 |
| Website | streamex.com |
Stock Details
| Ticker Symbol | STEX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001530766 |
| CUSIP Number | 09073N300 |
| ISIN Number | US09073N3008 |
| Employer ID | 26-4333375 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Karl Henry McPhie | Chief Executive Officer and Director |
| Ferdinand Groenewald | Interim Chief Financial Officer and Principal Accounting Officer |
| Mitchell Williams CFA | Chief Investment Officer |
| Lora Mikolaitis | Chief Administrative Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2025 | 10-Q | Quarterly Report |
| Nov 10, 2025 | SCHEDULE 13D | Filing |
| Nov 10, 2025 | SCHEDULE 13D | Filing |
| Nov 6, 2025 | 8-K | Current Report |
| Nov 4, 2025 | 8-K | Current Report |
| Nov 3, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 31, 2025 | 8-K | Current Report |
| Oct 29, 2025 | 8-K | Current Report |
| Oct 3, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Sep 15, 2025 | SCHEDULE 13G/A | Filing |